Details for New Drug Application (NDA): 020291
✉ Email this page to a colleague
The generic ingredient in COMBIVENT is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.
Summary for 020291
Tradename: | COMBIVENT |
Applicant: | Boehringer Ingelheim |
Ingredient: | albuterol sulfate; ipratropium bromide |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;INHALATION | Strength | EQ 0.09MG BASE/INH;0.018MG/INH | ||||
Approval Date: | Oct 24, 1996 | TE: | RLD: | No |
Expired US Patents for NDA 020291
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Boehringer Ingelheim | COMBIVENT | albuterol sulfate; ipratropium bromide | AEROSOL, METERED;INHALATION | 020291-001 | Oct 24, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription